Endeavor Sprint
Zotarolimus-Eluting Coronary Stent System

Clinical Outcomes

The Endeavor® Sprint Zotarolimus-Eluting Coronary Stent System has proven performance in a comprehensive and robust clinical program:

  • More than 10,000 Endeavor DES patients in clinical trial program
  • Over 1200 Endeavor DES patients studied to 5 years
  • Similar clinical performance across multiple randomized clinical trials and real-world registries

 

Randomized Trials

ENDEAVOR IV

Endeavor_TVFto36Mnths

p-Values were calculated by logrank test. p-Values for outcome differences are unadjusted for multiple comparisons.
ENDEAVOR IV primary endpoint: noninferiority of Endeavor DES to Taxus DES at 9 months (target vessel failure).
RRR = relative risk reduction.

Endeavor_CDMIto36Mnths

* ENDEAVOR IV was not specifically designed or powered to individually compare CD/MI.
ENDEAVOR IV primary endpoint: Noninferiority of Endeavor DES to Taxus DES at 9 months (target vessel failure).
p-Values were calculated by logrank test. p-Values for outcome differences are unadjusted for multiple comparisons.
RRR = relative risk reduction.

Endeavor_ARC12-36MVLST

p-Values were calculated by logrank test. p-Values for outcome differences are unadjusted for multiple comparisons.
ENDEAVOR IV was not specifically designed or powered to individually compare VLST.
RRR = relative risk reduction.

Endeavor vs. Taxus: Late TLR Catch-up

p-Value was calculated by Fisher’s exact test.
p-Values for outcome differences are unadjusted for multiple comparisons.
ENDEAVOR IV was not specifically designed or powered to individually compare TLR.

ENDEAVOR III

Endeavor DES Displayed Low and Sustained TLR Rates to 5 Years

ENDEAVOR III primary endpoint: In-segment late lumen loss by QCA at 8 months. 0.36 for Endeavor DES vs. 0.13 for Cypher DES (p<0.001).

endeavor_a
 
Endeavor323323280272263257
CI (%)0.06.66.97.37.78.0
Cypher1131131071019791
CI (%)0.03.54.54.56.56.5

p-Values are unadjusted for multiple comparisons.
p-Values were calculated by logrank test.
ENDEAVOR III was not specifically designed or powered to individually compare TLR.

ENDEAVOR Pooled Analysis

Endeavor DES vs. Driver BMS pooled data

ENDEAVOR Pooled 5 year: EI (5 year); EII (5 year); EII CA (5 year); EIII (5 year); EIV (3 year); E pk (3 year).
p-values are unadjusted for multiple comparisons. Pooled Kaplan-Meier analysis.

Significant reduction in CD/MI vs. BMS at 5 years in pooled analysis 
 
Days0360720108014401800
Endeavor
Events n (%)
2132
30 (1.4)
2102
60 (2.8)
2009
72 (3.4)
1951
79 (3.8)
1649
87 (4.4)
1168
96 (5.2)
Driver
Events n (%)
596
15 (2.5)
581
27 (4.5)
555
34 (5.8)
544
39 (6.6)
529
41 (7.0)
523
49 (8.4)

ENDEAVOR Pooled 5 year: EI (5 year); EII (5 year); EII CA (5 year); EIII (5 year); EIV (3 year); E pk (3 year).
p-values are unadjusted for multiple comparisons.
p-value was calculated by log-rank test.

Last updated: 26 Feb 2013

Medtronic Vascular

(877) 526-7890